Silva J E, Larsen P R
J Clin Invest. 1985 Dec;76(6):2296-305. doi: 10.1172/JCI112239.
Previous reports suggest that a type II iodothyronine 5'-deiodinase may become the main enzymatic pathway for extrathyroidal triiodothyronine (T3) generation when the enzyme levels are sufficiently elevated and/or liver and kidney type I 5'-deiodinase activity is depressed. The present studies assessed the potential of brown adipose tissue (BAT) type II 5'-deiodinase to generate T3 for the plasma pool. BAT 5'-deiodination (BAT 5'D) was stimulated by either short- (4 h) or long-term (7 wk) cold exposure (4 degrees C). Long-term cold exposure increased thyroxine (T4) secretion 40-60% and extrathyroidal T3 production three-fold. In cold-adapted rats treated with propylthiouracil (PTU), extrathyroidal T3 production was 10-fold higher than in PTU-treated rats maintained at room temperature. Cold did not stimulate liver or kidney 5'D, but the cold-adapted rats showed a six- to eightfold higher BAT 5'D content. PTU caused greater than 95% inhibition of liver and kidney 5'D, but did not affect BAT 5'D. Thyroidectomized rats maintained on 0.8 micrograms of T4/100 g of body weight (BW) per day were acutely exposed to 4 degrees C. In rats given 10 mg of PTU/100 g of BW, 4 h of cold exposure still caused a 12-fold increase in BAT 5'D, a 2.3-fold increase in plasma T3 production, and a 4.8-fold increment in the locally produced T3 in BAT itself. All these responses were abolished by pretreatment with the alpha 1-antiadrenergic drug prazosin. Regardless of the ambient temperature, liver 5'D activity was greater than 90% inhibited by PTU. These results indicate that BAT can be a major source of plasma T3 under suitable circumstances such as acute or chronic exposure to cold. Furthermore, BAT 5'D activity affects BAT T3 content itself, suggesting that thyroid hormone may have a previously unrecognized role in augmenting the thermogenic response of this tissue to sympathetic stimulation. Such interactions may be especially important during the early neonatal period in humans, a time of marked thermogenic stress.
先前的报道表明,当II型碘甲状腺原氨酸5'-脱碘酶水平充分升高和/或肝脏和肾脏I型5'-脱碘酶活性受到抑制时,它可能成为甲状腺外三碘甲状腺原氨酸(T3)生成的主要酶促途径。本研究评估了棕色脂肪组织(BAT)II型5'-脱碘酶为血浆池生成T3的潜力。短期(4小时)或长期(7周)冷暴露(4℃)均可刺激BAT 5'-脱碘作用(BAT 5'D)。长期冷暴露使甲状腺素(T4)分泌增加40 - 60%,甲状腺外T3生成增加三倍。在用丙硫氧嘧啶(PTU)治疗的冷适应大鼠中,甲状腺外T3生成比维持在室温的PTU治疗大鼠高10倍。寒冷并未刺激肝脏或肾脏的5'D,但冷适应大鼠的BAT 5'D含量高6至8倍。PTU对肝脏和肾脏的5'D抑制率超过95%,但不影响BAT 5'D。每天给予0.8微克T4/100克体重(BW)维持的甲状腺切除大鼠急性暴露于4℃。在给予10毫克PTU/100克BW的大鼠中,4小时冷暴露仍使BAT 5'D增加12倍,血浆T3生成增加2.3倍,BAT自身局部生成的T3增加4.8倍。所有这些反应均被α1 - 抗肾上腺素能药物哌唑嗪预处理所消除。无论环境温度如何,PTU均可使肝脏5'D活性受到大于90%的抑制。这些结果表明,在诸如急性或慢性冷暴露等合适情况下,BAT可以是血浆T3的主要来源。此外,BAT 5'D活性影响BAT自身的T3含量,这表明甲状腺激素可能在增强该组织对交感神经刺激的产热反应中具有先前未被认识到的作用。这种相互作用在人类新生儿早期可能尤为重要,这是一个产热应激明显的时期。